Valuation: Yunnan Botanee Bio-Technology Group Co.LTD

Market Cap 13.68B 2.02B 1.77B 1.63B 1.51B 2.84B 194B 2.89B 19.46B 7.63B 95B 7.59B 7.42B 327B P/E 2026 *
21.4x
P/E 2027 * 18.6x
Enterprise Value 12.03B 1.78B 1.55B 1.43B 1.33B 2.5B 171B 2.54B 17.11B 6.71B 83.53B 6.67B 6.52B 288B EV / Sales 2026 *
1.98x
EV / Sales 2027 * 1.79x
Free-Float
50.21%
Yield 2026 *
2.29%
Yield 2027 * 2.42%
May. 21 Yunnan Botanee Bio-Technology Group Co.LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2025, Payable on 28 May 2026 CI
Apr. 29 Yunnan Botanee Bio-Technology Group Co.LTD announces an Equity Buyback for CNY 200 million worth of its shares. CI
Apr. 28 Jefferies Adjusts Yunnan Botanee Bio-Technology's Price Target to 40 Yuan from 42 Yuan, Keeps at Hold MT
Apr. 26 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Apr. 22 Yunnan Botanee Bio-Technology Group Co.LTD authorizes a Buyback Plan. CI
Mar. 02 Yunnan Botanee Bio-Technology Group Co.LTD Approves Cash Dividend on A Shares for the Third Quarter of 2025, Payable on 10 March 2026 CI
Feb. 11 Yunnan Botanee Bio-Technology Group Co.Ltd Proposes Dividend for the Third Quarter of 2025 CI
Jan. 12 Yunnan Botanee Bio-Technology Group's shareholder plans to cut stake RE
Dec. 09 Suzhou Zisong Medical Technology Co., Ltd announced that it has received funding from Yunnan Botanee Bio-Technology Group Co.LTD, Beijing Zhongguancun Qihang Venture Capital and other investors CI
25-10-27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-29 Macquarie Downgrades Yunnan Botanee Bio-Technology Group to Underperform from Outperform; Price Target is 42 Yuan MT
25-08-27 Yunnan Botanee Bio-Technology Group Co.LTD Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-07-24 Yunnan Botanee Bio-Technology's shareholder to unload shares RE
1 day+4.74%
1 week+3.77%
Current month+3.05%
1 month-4.64%
3 months-13.11%
6 months-21.27%
Current year-18.03%
1 week 30.58
Extreme 30.58
33.05
1 month 29.48
Extreme 29.48
34.24
Current year 29.48
Extreme 29.48
49.79
1 year 29.48
Extreme 29.48
51.8
3 years 29.48
Extreme 29.48
109.3
5 years 29.48
Extreme 29.48
272.72
10 years 29.48
Extreme 29.48
289.35
Manager TitleAgeSince
Chief Executive Officer 63 2016-11-30
Director of Finance/CFO 44 2019-03-05
Corporate Officer/Principal 47 2023-02-27
Director TitleAgeSince
Chairman 63 2014-05-31
Director/Board Member 50 2012-10-31
Director/Board Member 44 2014-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+4.74%+3.77%-27.46%-64.47% 1.93B
-0.05%-0.56%+2.99%-8.54% 231B
-1.27%-4.83%+32.64% - 49B
+2.80%-5.98%+121.30% - 9.43B
+1.41%+5.05%+18.43%-52.79% 7.26B
+0.67%-4.51%-13.47%+14.29% 4.99B
+2.44%+0.34%-30.38%-37.30% 4.26B
+2.86%+4.95%-7.57%-9.83% 3.77B
+4.57%+3.63%-27.67%-46.90% 3.32B
+2.34%+2.50%-20.06%-47.70% 2.58B
Average +2.09%+0.60%+4.88%-31.66% 31.79B
Weighted average by Cap. +0.12%-2.20%+9.90%-11.13%

Financials

2026 *2027 *
Net sales 6.06B 895M 782M 723M 668M 1.26B 86B 1.28B 8.63B 3.38B 42.11B 3.36B 3.29B 145B 6.65B 982M 859M 794M 733M 1.38B 94.37B 1.41B 9.46B 3.71B 46.21B 3.69B 3.61B 159B
Net income 642M 94.75M 82.8M 76.54M 70.72M 133M 9.1B 136M 913M 358M 4.46B 356M 348M 15.34B 740M 109M 95.53M 88.31M 81.59M 154M 10.5B 156M 1.05B 413M 5.14B 411M 402M 17.7B
Net Debt -1.65B -244M -213M -197M -182M -343M -23.41B -349M -2.35B -921M -11.46B -915M -895M -39.47B -1.74B -256M -224M -207M -191M -360M -24.63B -367M -2.47B -969M -12.06B -963M -942M -41.53B
Logo Yunnan Botanee Bio-Technology Group Co.LTD
Yunnan Botanee Bio-Technology Group Co Ltd is a China-based company mainly engaged in the production of cosmetics. The Company's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The Company is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care. The Company primarily operates in the domestic market.
Employees
3,574
Date Price Change Volume
26-07-14 CN¥32.47 +4.74% 10,255,690
26-07-14 CN¥31.00 +0.29% 4,990,404
26-07-13 CN¥30.91 -2.49% 4,830,479
26-07-10 CN¥31.70 +2.42% 7,390,132
26-07-09 CN¥30.95 -1.43% 5,108,132
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
32.47CNY
Average target price
44.54CNY
Spread / Average Target
+37.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300957 Stock